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Abstract
Genomic imprinting is a complex epigenetic mechanism of transcriptional control that utilizes DNA methylation and histone
modifications to bring about parent-of-origin specific monoallelic expression in mammals. Genes subject to imprinting are
often organised in clusters associated with large non-coding RNAs (ncRNAs), some of which have cis-regulatory functions.
Here we have undertaken a detailed allelic expression analysis of an imprinted domain on mouse proximal chromosome 10
comprising the paternally expressed Plagl1 gene. We identified three novel Plagl1 transcripts, only one of which contains
protein-coding exons. In addition, we characterised two unspliced ncRNAs, Hymai, the mouse orthologue of HYMAI, and
Plagl1it (Plagl1 intronic transcript), a transcript located in intron 5 of Plagl1. Imprinted expression of these novel ncRNAs
requires DNMT3L-mediated maternal DNA methylation, which is also indispensable for establishing the correct chromatin
profile at the Plagl1 DMR. Significantly, the two ncRNAs are retained in the nucleus, consistent with a potential regulatory
function at the imprinted domain. Analysis with catRAPID, a protein-ncRNA association prediction algorithm, suggests that
Hymai and Plagl1it RNAs both have potentially high affinity for Trithorax chromatin regulators. The two ncRNAs could
therefore help to protect the paternal allele from DNA methylation by attracting Trithorax proteins that mediate H3 lysine-4
methylation.
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Introduction
Genomic imprinting is an epigenetic form of transcriptional
regulation that results in the monoallelic expression of genes from
the paternal or maternal allele [1]. Currently there are around 120
confirmed imprinted genes in the mouse, with approximately 60
showing conserved imprinted expression in humans (http://igc.
otago.ac.nz/home.html). Imprinted genes have been shown to
play important roles in development, and code for proteins with
diverse biological activities.
The allele-specific expression of imprinted genes is mediated
by CpG rich sequence elements that show allelic DNA
methylation [2]. These differentially methylated regions (DMRs)
result from methylation deposition during oogenesis or sper-
matogenesis, specifically by the DNMT3A/DNMT3L de novo
methyltransferase complex [3–5]. Following fertilization, the
allelic methylation is maintained throughout development. In
somatic tissues, most DMRs are also marked by allelic histone
modifications, highlighting interplay between these two epige-
netic systems [6]. Recently, non-coding RNAs (ncRNAs) have
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ferases to imprinted gene promoters, thus revealing the diversity
of epigenetic mechanisms involved in the imprinting process
[7,8].
The Plagl1 (also known as Zac1) imprinted gene maps to mouse
chromosome 10. The human orthologue is located on human
chromosome 6 [9,10]. This paternally expressed gene encodes a
zinc finger transcription factor with seven C2H2-type zinc-fingers
that regulates apoptosis and cell cycle [11]. Loss of PLAGL1
expression is frequently observed in many human tumours,
consistent with its proposed role as a tumour-suppressor gene
[12]. Over-expression of the human PLAGL1 gene is thought to be
responsible for Transient Neonatal Diabetes Mellitus (TNDM), a
genetic disease characterised by severe intrauterine growth
restriction and insulin dependence in neonates [13]. This over-
expression can result from paternal uniparental isodisomy,
paternally inherited duplications of 6q24–q25 or epigenetic
mutations in which the maternal allele adopts a paternal
epigenotype, resulting in biallelic expression [14]. A paternally
expressed ncRNA, HYMAI, located in the first intron of human
PLAGL1, is also over-expressed in TNDM patients, but the
function of this transcript remains unknown [13].
To explore the mechanisms regulating PLAGL1 imprinted
expression, we performed a comparative characterisation of the
orthologous domain on mouse chromosome 10. We identified
numerous paternally expressed ncRNAs, which we propose may
be involved in maintaining the paternal allele in a transcriptionally
permissive state.
Results
Novel Imprinted Plagl1 Isoforms
To first determine the size of the Plagl1 gene in mouse, we
interrogated the working draft sequence browser (NCBI26/mm8,
Feb 2006). In accordance with previous reports, we find that the
Plagl1 gene covers ,71 kb and contains 12 exons [10]. These
include numerous alternatively spliced exons in the 59UTR
originating from two promoter regions embedded within two
different CpG islands (Figure 1A). The majority of transcripts arise
from the promoter (P1) within the DMR, whereas less abundant
transcripts originate from an unmethylated CpG island ,30 kb
upstream (P2) (reference EST FJ425893). The open reading frame
(ORF) for these transcripts is restricted to the last two exons,
resulting in a full-length protein of 705 amino acids. All full-length
transcripts share a common 39UTR, with a polyadenylation signal
24 bp from the stop codon.
As a result of expressed sequence tag (EST) alignments, we
identified three additional Plagl1 transcripts (Figure 1A). A novel
Plagl1 transcript (reference EST BM894919) originates from a
unique promoter region (P3) 59 to the exon 7 acceptor site
(gtccaag//GTCTCTT or ctcacag/GTTTGAG) of P1-Plagl1
transcript, with a 59UTR that extends at least 300 bp into the
upstream intron mapping to an interval containing a cluster of
CAGE (59Cap Analysis Gene Expression) tags. This transcript
includes the last three exons and therefore incorporates the full-
length Plagl1 ORF. The remaining two transcripts (reference
ESTs CJ065374 and AI607573) originate from within the Plagl1-
DMR region but terminate after exons 4 and 5 respectively.
These different RNAs contain unique 39UTRs, extending
beyond the exon boundaries into the P1-Plagl1 introns and do
not include the Plagl1 ORF. Northern blot analysis using a Plagl1
exon 2–3 probe revealed, in addition to the 2 major splice
variants, multiple transcripts between 700 bp and 1.7 kb (Figure
S1). Using various strategically designed RT-PCR primers, we
were able to confirm paternal expression of all novel Plagl1
transcripts in RNA derived from E18.5 (B x C) F1 mouse tissues
(Figure 1B).
Conserved Expression of Hymai in Mouse
The human PLAGL1 region contains the paternally expressed
HYMAI transcript. This non-coding RNA has a transcription start
site located within the PLAGL1-DMR. However, DNA sequence
from this region shows only weak conservation between humans
and mouse (data not shown) and no mouse Hymai is described on
the UCSC sequence browser or in Genbank databases. We set out
to determine whether this non-coding RNA is conserved in mouse.
We utilised allelic RT-PCR amplifications restricted to intron 1 of
P1-derived Plagl1 transcript. We observed paternal expression of
an RNA in various mouse tissues from E18.5 embryos (Figure 1B).
Using 59 and 39 RACE, we were able to map the extent of this
transcript, which we named ‘Hymai’. We identified four different
transcriptional start sites (TSS) for Hymai, spread over a 19 bp
interval embedded within the Plagl1-DMR (Figure S2). Using the
same RACE-ready cDNA from E18.5 embryos, we were able to
show that P1-Plagl1 transcript originates from an overlapping
47 bp region, with neither P1-Plagl1 nor Hymai being associated
with a TATA-box. Using 39RACE, we show that Hymai
terminates ,5 kb from the TSS interval, with multiple 39 RACE
products (last base chr10: 12815696 and chr10: 12815706 of
mouse genome NCBI37/mm9), the longest transcript terminating
46 bp after a canonical polyadenylation signal (AATAAA). We
were unable to confirm a single band on northern blot analysis,
since the expression of this transcript is below the detectable limits
of the technique. Analysis of the open reading frame revealed that
Hymai has no obvious ORF (Figure S 2).
Paternal Expression of a Novel Plagl1 Internal Transcript,
Plagl1it
Through examination of the UCSC sequence browser we
identified 12 ESTs of various sizes transcribed from the same (+)
strand as Plagl1, located within intron 5 of P1-Plagl1. The largest
EST, AK087432, is 2964 bp, representing an intronless transcript
with no ORF, that we named Plagl1 intronic transcript (Plagl1it)
(Figure 1B; Figure S2). Using RACE, we found that this transcript
initiates within intron 5 of P1-Plagl1 and is at least 3.6 kb, with its
59 end overlapping the 39UTR of the paternally expressed EST
AI607573 by ,400 bp. Northern blot analysis confirmed the
presence of a faint band of between 3.5–kb (Figure S1). Using
RACE and RT-PCR we were unable to link Plagl1it to Plagl1,
confirming this is an independent overlapping transcript and not
an alternative Plagl1 exon or UTR (Figure S2). Using allele-specific
RT-PCR, we were able to show that this transcript is expressed
solely from the paternal chromosome in different mouse tissues
(Figure 1B).
Expression of Hymai and Plagl1it is Uniformly Low
Throughout Development
Next, we set out to analyse the tissue-specificity of expression for
the novel transcripts. Using quantitative RT-PCR we determined
the abundance of the transcripts in placenta, brain and
decapitated embryos at E11.5, E12.5, E14.5, E18.5 and in
addition to brain, liver, kidney and muscle from both newborn and
adult mice (Figure S1). We observed that Plagl1 expression was
consistently higher than both Hymai and Plagl1it in all tissues and
developmental stages analysed. All genes show a marked decrease
in expression after birth, in both newborn and adult tissues.
Novel ncRNAs at the Plagl1 Locus
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As a first step to explore whether Hymai and Plagl1it could have
functional roles, we determined the cellular localisation of these
ncRNAs. We performed qRT-PCR on nuclear, cytoplasmic and
total RNA isolated from mouse embryonic fibroblasts (MEF) cells.
The efficiency of the nuclear separation was confirmed using the
U937 snoRNA and paternally expressed Airn ncRNAs that have
been shown previously to not be exported to the cytoplasm. We
observed residual Airn in the cytoplasmic fraction, suggesting slight
nuclear RNA contamination only detectable when analysing
highly expressed nuclear retained transcripts. The Igf2r mRNA
was used as a control for a transcript that is exported to the
cytoplasm [15]. Quantitative RT-PCR analysis revealed that the
Plagl1 transcript is efficiently exported to the cytoplasm for
translation, whereas the Hymai ncRNA is retained in the nucleus.
The Plagl1it transcript is present in both the nucleus and
cytoplasm, but is more abundant in the nuclear fraction
(Figure 2A).
To determine the stability of Hymai and Plagl1it in MEFs,
actinomycin (ActD) was used to inhibit transcription. We used C-
Myc and the unspliced Airn transcripts as controls for RNAs with
short half-life and Gapdh and Igf2r as control for RNAs with long
half-lives [8,15]. Figure 2B shows that after 12 hours treatment
with ActD the C-Myc and Airn mRNAs are largely depleted,
whereas Gapdh and Igf2r are not affected. The Plagl1 transcript
remains abundant under these ActD conditions, suggesting that it
is a highly stable transcript. However, both Hymai and Plagl1it are
diminished after 12 hours to levels that are similar to C-Myc and
Airn, indicating that these ncRNAs are unstable transcripts.
DNMT3L is Indispensable for Hymai, Plagl1it and Plagl1
Imprinting
DNA methylation inherited from the maternal germline
requires the DNMT3L/DNMT3A complex [3,4]. Using bisul-
phite DNA sequencing, we were able to confirm that the CpG
island overlapping the P1-Plagl1 and Hymai transcription start sites
Figure 1. Schematic overview of the mouse chromosome 10 imprinted domain. (A) Map of the Plagl1 locus, showing the location of the
various imprinted transcripts and CpG islands (paternally expressed transcripts are in blue; biallelically expressed transcripts are in grey). Arrows
represent direction of transcription. (B) The allelic expression of the various transcripts in embryonic tissues in reciprocal mouse crosses (for clarity
only (B6C) F1 tissues are shown).
doi:10.1371/journal.pone.0038907.g001
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unmethylated CpG island. The promoters of Plagl1it and P3-Plagl1
initiate from regions of low CpG content that display partial, but
not allelic DNA methylation (Figure 3A). To assess if the maternal
allelic silencing of Hymai, Plagl1it and the various Plagl1 transcripts
requires maternal germline DNA-methylation, we used qRT-PCR
on mouse embryos that had inherited a deletion of the Dnmt3l gene
from a homozygous mutant mother [3]. Lack of this essential
imprinting factor led to the loss of maternal methylation at the
Plagl1-DMR, and increased expression of all transcripts in targeted
E8.5 embryos due to reactivation of the maternal allele (Figure 3B).
The Plagl1-DMR Chromatin Profile Requires Allelic DNA
Methylation
Recent studies have suggested that there is a mechanistic link
between DNA and histone methylation at imprinted DMRs [6].
To determine if there was a link between allelic DNA-methylation
and any histone modifications present at the Plagl1-DMR, we first
looked for the presence of modifications by allelic chromatin
immunoprecipitation on whole embryos followed by discrimina-
tion of the parental alleles in the precipitated chromatin fractions.
Our analysis focused on different modifications of histone H3 and
H4; pan-acetylation of H3, acetylation of H3 lysine-9 (H3K9ac)
and H3 lysine 4 dimethylation (H3K4me2) as markers of active
chromatin; and the repressive marks of H3 lysine 9 trimethylation
(H3K9me3) and H3 lysine 27 trimethylation (H3K27me3), along
with the histone H4 lysine 20 trimethylation (H4K20me3).
We ascertained allelic enrichment using a polymorphic region
between inbred mouse strains that maps within 200 bp of the CpG
island associated with the Plagl1-DMR. Within this region
H3K4me2 and H3K9ac were strongly enriched specifically on
the unmethylated paternal allele (Figure 3C). The same regions
showed precipitation of the repressive markers H3K9me3,
H3K27me3 and H4K20me3 on the DNA-methylated maternal
allele. We extended our analysis to include the promoter regions of
P2-Plagl1, which maps within an unmethylated CpG island, and
Plagl1it, whose promoter is not associated with a CpG island. In
Figure 2. Cellular localization and RNA stability of the ncRNAs. (A) Distribution of the various transcripts in the nuclear (dark grey) and
cytoplasmic (black) fractions, compared to total RNA (light grey). U937 snoRNA and Airn are nuclear-retained controls, whereas Igf2 is cytoplasm-
exported control. (B) Abundance of the various transcripts after exposure to Actinomycin D to determine RNA stability. The relative expression values
of the control untreated samples are set to 1 (light grey bars) for each transcript. C-Myc and Airn are control transcripts for with short half-life; Gapdh
and Igf2r are long half-life controls.
doi:10.1371/journal.pone.0038907.g002
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the presence of allelic histone modifications is restricted to the
DMR region (data not shown).
To assess whether the allelic histone modifications we observe at
the Plagl1-DMR require the maternally derived DNA methylation,
we performed allelic ChIP on Dnmt3l 2/+ embryos. In agreement
with observations at other imprinted DMRs [6], we detect a
dramatic effect on histone modification distribution, with the lack
of allelic enrichment due to ‘‘paternalization’’ of the maternal
allele, as a result of increased H3K4me3 and a concomitant
reduction of H3K9me3 and H4K20me3 (Figure 3C).
Hymai and Plagl1it Potentially Interact with Active
Chromatin Regulatory Factors
To determine whether Hymai and/or Plagl1it could be involved
in maintaining the active state of the paternal allele of the Plagl1-
DMR, we performed a prediction of their interaction propensities
against four Trithorax proteins (ASH1/KMT2H, MLL1/
KTM2A, WDR5, CFP1) using the recently published catRAPID
method [16]. CatRAPID allows evaluation of the interaction
potential of polypeptides and RNAs using their physiochemical
properties, with initial studies revealing high interactions propen-
sities for the ncRNAs Xist and HOTAIR with Polycomb repressive
complex proteins (interaction propensities 76–99% and 69–99%,
respectively). In addition, CatRAPID was able to accurately
predicted RNA binding of the human RNase P proteins
(interaction propensities 68–99%) and discriminate RNA binding
(interaction propensity .65%) and non-binding (interaction
propensity ,5%) proteins of the human ribonuclease mitochon-
drial RNA processing (MRP) complex [16].
In our analysis we used ncRNAs Evx1as and HOTTIP as
controls because they are known from experimental work to
directly recruit MLL1 and WDR5 proteins to HOX gene loci
[17,18]. We observed moderate to high interaction propensities
between Evx1as and various functional domains of the MLL1
protein, and between HOTTIP and WDR5 (Figure 4A). Interest-
ingly both are predicted to interact strongly with the CFP1 PHD
and Ash1 SET-postSET regions. Subsequent analysis using our
imprinted ncRNAs revealed that Hymai and Plagl1it are highly
prone to interaction; in particular they have strong binding
Figure 3. Analysis of Plagl1 region in Dnmt3l 2/+. (A) The methylation status of the Plagl1 promoter regions in wild type +/+ and Dnmt3l 2/+
embryos examined by bisulphite PCR. Each circle represents a single CpG dinucleotide on a DNA strand, a methylated cytosine (N)o ra n
unmethylated cytosine (#). (B) RT-PCRs on cDNA generated with (+) and without (2) reverse transcriptase show an increase in the expression of the
imprinted transcripts in Dnmt3l2/+ embryos as a result of reactivation of the maternal allele. (C) The histone modification signature of the Plagl1-
DMR in wild type B6C embryos, and after targeted deletion of the Dnmt3l gene. DNA extracted from antibody bound (B) and unbound (U) chromatin
fractions were subject to either qPCR or PCR and SSCP analysis with primers that can discriminate parental alleles.
doi:10.1371/journal.pone.0038907.g003
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Plagl1it have negligible propensity for interaction with the
Polycomb repressive complex protein EZH2, which trimethylates
H3K27 to repress transcription (Figure 4B). Finally, we compared
the interaction propensities for Hymai and the human orthologue
HYMAI. We observe that despite having different sequences, and
HYMAI being subject to splicing, the two transcripts have similar
potential interactions (Figure 4C), with 39 regions having the
highest interaction propensities (data not shown). Overall the
murine Hymai could interact with MLL1 slightly less than human
HYMAI, but both display high interaction propensities for ASH1
SET-postSET domains and for CFP1 (Figure 4C). Taken together,
our results suggest that both Hymai and Plagl1it may interact with
chromatin machinery that confers a permissive chromatin state.
Discussion
Here we show a detailed investigation of the genomic
organisation of the mouse Plagl1 domain. As in humans, Plagl1
transcripts can originate from multiple promoters, one of which is
a DMR previously shown to be methylated in the female germline
and therefore likely to be the ICR for this region [10,19]. A second
alternative promoter located ,30 kb upstream is within an
unmethylated CpG island. This promoter is orthologous with
the human P2-PLAGL1 which gives rise to biallelically expressed
transcripts in lymphocytes and pancreas [20]. In mouse,
transcription from this promoter is low in somatic tissues, however
the primary function of this promoter may be to allow
transcription across the P1-Plagl1 promoter CpG island in growing
oocytes. This has been proposed to be important for the
establishment of the allelic DNA-methylation at this DMR [21].
In addition to the alternative transcripts of Plagl1, we show the
presence of two additional ncRNAs, Hymai and Plagl1it. In keeping
with other reported ncRNAs, these are expressed at a lower level
than nearby mRNAs, consistent with the hypothesis that ncRNAs
may fulfil a regulatory function [22]. We were able to successfully
map the TSS and polyadenylation sites for both Hymai and Plagl1it
using RACE-ready cDNAs, indicating that these transcripts
comprise rare ncRNAs that are polyadenylated and have 59-
Caps. The reason for the nuclear enrichment of these ncRNA is
unknown, as the majority of polyadenylated RNAs are exported to
the cytoplasm [23,24]. However, the lack of RNA splicing may be
a significant factor in the nuclear retention, as has been described
for the various full-length and spliced isoforms of Airn [16] and
other mRNAs [24].
The precise roles of Hymai/HYMAI and Plagl1it are unclear, but
it is likely that they have a different function to the other known
imprinted long ncRNAs such as Airn and Kcnq1ot1 due to their
different affinities for chromatin remodelling enzymes. Airn and
Kcnq1ot1 have been shown to attract histone methyltransferases
G9a/KTM1C and EZH2/KMT6, and are involved in cis-
silencing of nearby genes [8,24,25]. However, recent studies
demonstrated that large ncRNAs can also guide the permissive
H3K4 histone methyltransferase machinery to target genes in
mouse ES cells and MEFs [17,18] and can act as local enhancers
[26]. Thus, unlike other imprinted ‘‘repressive’’ ncRNAs, our data
suggests that Hymai and Plagl1it could act to keep the paternal
allele unmethylated and in a transcriptionally permissive state. In
fitting with this hypothesis, we observe that Hymai and Plagl1it are
unstable transcripts, which presumably ensures they stay near the
site of transcription, preventing their action in trans on the
maternal allele within the same nucleus. Our in silico analysis using
catRAPID suggests that Plagl1it and the mouse and human Hymai/
HYMAI may interact with various components of the Trithorax
group proteins, with potentially the highest specificity for SET-
proSET and zinc finger CXXC domains, in agreement with
previous in vitro experiments showing that these domains can bind
RNA [27,28]. In vitro demonstration of these interactions is
technically challenging since Hymai and Plagl1it are not expressed
at the levels required for RNA-ChIP in MEF cells. However, we
observe that WDR5 does precipitate preferentially on the paternal
unmethylated allele of the Plagl1-DMR (Figure S3) substantiating
our hypothesis.
Conclusions
Germline loss of methylation at the maternal allele of the
PLAGL1-DMR is known to result in TNDM [13,29]. In addition,
PLAGL1 has been suggested to play a role in numerous cancers,
including ovarian, breast and pituitary adenomas, with somatic
deletions or gains in methylation resulting in loss of expression of
this tumour suppressor gene [30]. We hypothesise that the newly
identified ncRNA could potentially guide the H3K4 methylation
machinery to the paternal allele of the PLAGL1-DMR, and thus
protect this region from pathological hypermethylation.
Materials and Methods
Mouse Crosses and Cell Lines
For the analysis of expression, wild type mouse embryos and
placentas were produced by crossing C57BL/6 (B) with Mus
musculus castaneus (C) mice. RNA and DNA from DNMT3L
2/+
mice (B6C) was isolated and extracted as previously described [3].
Animal husbandry and breeding were licensed by Direction
Departementale des Services Veterinaires (authorization number
34–104). Homozygous C57BL/6 mice of various gestational ages
were used for expression analysis. Mouse embryonic fibroblast cell
lines were established from both wild-type (B x C) F1 (Bourc’his
laboratory) and C57BL/6 (B) with Mus musculus molossinus (JF1) F1
(Feil laboratory) mice. The Institutional Review Board of Bellvitge
Institute for Biomedical Research granted scientific and ethical
approval for this study (PR232/09).
RNA Preparations
Total RNA from (B6C) F1 wild type embryos, Dnmt3l2/+
embryos and MEF cells was isolated using Trizol reagent
(Invitrogen) and subjected to double DNase 1 treatment to ensure
preparations were free of contaminating DNA. 1 ug of RNA was
used for first strand cDNA synthesis using Promega reagents
according to the manufacturer’s instructions. Nuclear and
cytoplasmic RNA was isolated from MEF cells using the Norgen
kit (Biotek corporation, Ontario, Canada) following manufacturers
instructions. cDNA was generated using 0.5 ug of cytoplasmic,
nuclear and total RNA.
Actinomycin Treatment
5610
5 MEF cells seeded per 10 cm dish were cultured for
36 hrs. At time point 0, the medium was removed; cells were
washed with PBS and then incubated with medium supplemented
with 10 mg/ml Actinomycin D (dissolved in ethanol). At each time
point (0, 12, 24 and 36 hrs) cells from a treated dish were
harvested for RNA using Trizol (Invitrogen).
59 and 39 RACE
Mouse E18.5 embryo Marathon-Ready cDNA (Clontech) was
used for RACE using the Advantage 2 polymerase kit (Clontech).
The PCR step was performed with the gene-specific primers
located in ESTs for Plagl1 and Plagl1it in combination with nested
adaptor oligonucleotides following manufacturers recommenda-
Novel ncRNAs at the Plagl1 Locus
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vector (Promega) and 20 colonies were sequenced using an ABI
prism 3100 DNA sequencer (Applied Biosystems). The full-length
sequences of Plagl1it and Hymai have been deposited in GenBank
and have been assigned the accession numbers JN595789 and
JN595790 respectively.
Northern Blot Analysis
To determine the size of Plagl1it, Hymai and the truncated Plagl1
transcripts, we used custom-made northern blots containing 20 mg
of total RNA extracted from CD1 embryos (Zyagen, San Diego,
USA). The blots were hybridised with an b-Actin probe prior to use
to confirm equal loading. Unique sequences for each transcript
were amplified by PCR, and the resulting amplicon probes were
radiolabelled with (
32P)CTP using the Ready-To-Go DNA
labelling Beads (Amersham). Hybridizations were carried out
overnight at 65uC and washed according to manufacturer’s
instructions.
RT-PCR Conditions
Allelic RT-PCRs, reactions were performed using primers that
flanked polymorphisms. The amplification cycle numbers for each
transcript were determined to be within the exponential phase of
the PCR, which varied for each gene, but was between 32–42
cycles. The subsequent amplicons were sequenced using both the
forward and reverse primers (Table S1 for primer sequences).
Real-time RT-PCR
All PCR amplifications were run in triplicate on a 7900 Fast
real-time PCR machine (Applied Biosystems) following the
manufacturers’ protocol. All primers were optimized using SYBR
Green (see additional data file 5 for primer sequences) and melt
curve analysis to ensure that amplicons were specific and free of
primer-dimer products. Thermal cycle parameters included Taq
polymerase activation at 95uC for 10 min for 1 cycle, repetitive
denaturation at 95uC for 15 sec, and annealing at 60uC for 1 min
for 40 cycles. All resulting triplicate cycle threshold (Ct) values had
to be with 1 Ct of each other. The quantitative values for each
triplicate were determined as a ratio with the level of Gapdh
expression (B-actin for actinomycin experiments), which was
measured in the same sample, and then averaged to provide
relative expression values.
Analysis of Allelic DNA-methylation
Approximately 1 mg DNA was subjected to sodium bisulphite
treatment and purified using the EZ GOLD methylation kit
(ZYMO, Orange, CA). Bisulphite PCR primers for each region
were used with Hotstar Taq polymerase (Qiagen, West Sussex,
UK) at 40 cycles and the resulting PCR product cloned into
pGEM-T easy vector (Promega) for subsequent sequencing (see
Table S1 for primer sequences).
Chromatin Immunoprecipitation (ChIP)
ChIP was carried out on wild type embryos, MEF cells and
Dnmt3l 2/+ embryos. ChIP was performed as previously described
[6] using the following Upstate Biotechnology antisera directed
against H3ac (06-599), H3K9ac (07-352), H3K4me2 (07-030),
H3K9me3 (060904589), H3K27me3 (07-449) and H4K20me3 (07-
463) (Upstate Biotechnology). DNA extracted from precipitated
chromatin fractions was PCR amplified, and parental alleles were
discriminated by either SSCP (PLAGL1-DMR) or by direct
sequencing. Polymorphisms within 1 kb of the CpG islands were
identified by interrogating SNP databases or through genomic
sequencing (see Table S1 for primer sequences and location). Only
ChIP sample sets that showed enrichment for additional imprinting
control regions were used in the analysis. Precipitation levels in the
ChIP samples were determined by real-time PCR amplification,
using SYBR Green PCR kit (Applied Biosystems). Each PCR was
run in triplicate and results are presented as percentage precipita-
tion and normalised to the level of the H19-DMD, since
methylation at this paternally methylated DMR is unaffected after
maternal transmission of the Dnmt3l deleted allele.
catRAPID Analysis
We employed the catRAPID algorithm to predict potential
interactions between ncRNAs and proteins [16]. This algorithm
was trained using RNA-protein pairs described in the NPInter
database. We calculated the average interaction propensity of each
RNA species (fragmented into ,1 kb segments because of
sequence length restrictions) against complete protein and unique
functional domains. Multiple domains adjacent in sequence were
joined together (e.g. three PHD domains in MLL1 and SET/
proSET regions). In the case of domain association with a size
,50 amino acids additional flanking amino acids were added
upstream and downstream.
Supporting Information
Figure S1 (A) Expression of Plagl1, Hymai and Plagl1it in various
tissues from embryos at different gestational stages (e=embryonic
day; NB=new born). (B) Northern blot analysis using probes
specific for Plagl1 exon 2–3, Plagl1it and Hymai. A single transcript
of less than 4 kb is detected for Plagl1it consistent with RACE and
RT-PCRs results. Truncated Plagl1 transcripts, between 700–
1.7 kb, correspond to CJ065374 and AI607573.
(TIF)
Figure S2 Mapping of the RACE products to determine
the extents of the novel transcripts and open reading
frame analysis. (A) The overlapping start sites for P1-Plagl1 and
Hymai. (B) analysis for open reading frame using DNA Strider for
Hymai. (C and D) The 59 and 39 ends of Plagl1it in relation to Plagl1
transcripts, and ORF analysis.
(TIF)
Figure S3 Chromatin immunoprecipitation of WDR5 in
MEF cells. (A) The upper panel shows PCR amplification of the
b-actin promoter control region and Plagl1-DMR in the WDR5-
ChIP. The lower panel is the genotypes of the input and IP (B x
C), showing preferential precipitation of the paternal allele
compared to input as calculated from relative area under the
nucleotide curve at the SNP position. (B) Confirmation of
preferential paternal enrichment by Hinf1 RFLP analysis.
(TIF)
Table S1 Table of PCR primer sequences.
(DOC)
Figure 4. CatRAPID analysis of ncRNA-protein interactions. (A) CatRAPID analysis reveals the interaction propensities of the control ncRNAs;
Evx1as with MLL1/KTM2A and HOTTIP with WDR5. (B) The interaction propensities for the control ncRNAs and for Hymai and Plagl1it with various
components (and sub-domains) of the H3K4 and H3K27 methylation machinery. (C) Similar ncRNA-protein interactions revealed by CatRAPID analysis
for Hymai (in black) and the human orthologue HYMAI (in red).
doi:10.1371/journal.pone.0038907.g004
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